Science News
from research organizations

Possibilities, challenges, and applications of next-generation sequencing

Date:
October 18, 2012
Source:
Association for Molecular Pathology
Summary:
A report provides a detailed and compelling overview of the landscape of next generation sequencing (NGS) technology and its clinical relevance and impact on improving patient care.
Share:
       
FULL STORY

The Association for Molecular Pathology (AMP) published the report of the Whole Genome Analysis (WGA) Working Group of the AMP Clinical Practice Committee in the November 2012 issue of The Journal of Molecular Diagnostics (JMD). Titled "Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing," the timely report provides a detailed and compelling overview of the landscape of next generation sequencing (NGS) technology and its clinical relevance and impact on improving patient care.

The issues addressed in the report are comprehensive, including …current technical, bioinformatic, and clinical implementation considerations, as well as medical applications, clinical utility, and ethical, legal, and education issues presented by genome-level diagnostic testing.

"NGS-related technologies and instrumentation introduced over the past decade have significantly alleviated the amount of resources required to conduct complex genomic analysis. "The possibilities of these technologies are numerous," noted, Iris Schrijver, AMP President and lead author of the report. "As the only Association whose members are experts specifically dedicated to the field of molecular pathology, AMP has the responsibility to initiate and lead the discussion on safe, effective and practical applications of next-generation sequencing."

The report illuminates the current state of NGS by calling out and highlighting the issues to be addressed in greater depth moving forward. "The next phase of reporting will include detailed studies of the validation, interpretation, and bioinformatics elements of NGS. We are excited to collaborate with other organizations to develop guidelines for application and quality assessment," said Jane Gibson, WGA Working Group Chair. "While this report is comprehensive, there is much yet to be done."


Story Source:

The above story is based on materials provided by Association for Molecular Pathology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Iris Schrijver, Nazneen Aziz, Daniel H. Farkas, Manohar Furtado, Andrea Ferreira Gonzalez, Timothy C. Greiner, Wayne W. Grody, Tina Hambuch, Lisa Kalman, Jeffrey A. Kant, Roger D. Klein, Debra G.B. Leonard, Ira M. Lubin, Rong Mao, Narasimhan Nagan, Victoria M. Pratt, Mark E. Sobel, Karl V. Voelkerding, Jane S. Gibson. Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing. The Journal of Molecular Diagnostics, 2012; 14 (6): 525 DOI: 10.1016/j.jmoldx.2012.04.006

Cite This Page:

Association for Molecular Pathology. "Possibilities, challenges, and applications of next-generation sequencing." ScienceDaily. ScienceDaily, 18 October 2012. <www.sciencedaily.com/releases/2012/10/121018162030.htm>.
Association for Molecular Pathology. (2012, October 18). Possibilities, challenges, and applications of next-generation sequencing. ScienceDaily. Retrieved May 26, 2015 from www.sciencedaily.com/releases/2012/10/121018162030.htm
Association for Molecular Pathology. "Possibilities, challenges, and applications of next-generation sequencing." ScienceDaily. www.sciencedaily.com/releases/2012/10/121018162030.htm (accessed May 26, 2015).

Share This Page: